Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 160
Immune Disorders Drugs 77
Genomics 76
Biopharmaceuticals 76
Biotechnology 50
Drug Discovery 47
Pharmaceuticals 45
Oncology Drugs 44
Musculoskeletal Disorders Drugs 43
Hematological Drugs 37
Biosimilars and Biosuperiors 33
Alzheimer's Disease Drugs 28
Cardiovascular Drugs 26
Clinical Trials 25
Infusions and Injectables 25
Allergy and Immunology 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Needles and Syringes 17
Neurology 16
Respiratory Drugs 16
Psoriasis Drugs 15
E-Healthcare 14
Infectious Diseases Drugs 14
Optical 12
Pharmaceutical Manufacturing 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Endocrine and Metabolic Disorders Drugs 11
Therapeutic Area 10
Diagnostics 10
Drug Delivery 10
Drugs by Therapeutic Area 9
Leukemia Drugs 9
Lymphoma Drugs 9
Analgesics 9
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Medical Devices 6
Oncology 6
Proteomics 5
Enzymes 5
Hospital Management 5
Cardiology 5
Schizophrenia Drugs 5
Company Reports 4
Mental Health 4
Neurology Devices 4
Laboratory Equipment 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Urology and Nephrology 2
Pharmacoeconomics 2
Lung Cancer Drugs 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

894 Results (Page 9 of 45)
- Relevance
  Sort by

Spinal Muscular Atrophy - Global Strategic Business Report

 Report
September 2025
189 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Epilepsy Treatment - Global Strategic Business Report

 Report
September 2025
483 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Tourette Syndrome Treatment - Global Strategic Business Report

 Report
September 2025
186 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4179EUR$4,750USD£3,626GBP

Self-Injection Devices - Global Strategic Business Report

 Report
September 2025
383 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Digital Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business and Key Geographical RegionsModel, Target Therapeutic Area

 Report
February 2025
565 Pages
Global

From

€4222EUR$4,799USD£3,663GBP

Edema Clinical Trials - Global Strategic Business Report

 Report
September 2025
461 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1759EUR$2,000USD£1,527GBP

Psoriatic Arthritis Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4354EUR$4,949USD£3,778GBP

Chronic Plaque Psoriasis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1759EUR$2,000USD£1,527GBP

RNA Based Therapeutics and Vaccines Market Report 2022-2032

 Report
October 2022
213 Pages
Global

From

€4712EUR$5,543USD£3,950GBP

Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Regional Outlook and Forecast, 2021-2027

 Report
February 2022
159 Pages
Global

From

€3167EUR$3,600USD£2,748GBP

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

 Report
July 2024
120 Pages
Global

From

€5234EUR$5,950USD£4,542GBP

Acute Ischemic Stroke Therapeutics Market 2024-2028

 Report
September 2024
184 Pages
Global

From

€2199EUR$2,500USD£1,908GBP

Generic Central Nervous System Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€3950EUR$4,490USD£3,427GBP

Insulin Biosimilars Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3950EUR$4,490USD£3,427GBP

Ophthalmology Drugs & Devices Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3651EUR$4,150USD£3,168GBP

Neurology Clinical Trials Market Report 2023-2033

 Report
January 2023
262 Pages
Global

From

€4712EUR$5,543USD£3,950GBP

Retinitis Pigmentosa (Retinitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
206 Pages
Global

From

€1759EUR$2,000USD£1,527GBP

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Indication by Study Design, By Indication by Phase, By Value Chain, By Region, And Segment Forecasts, 2025 - 2030

 Report
June 2025
120 Pages
Global

From

€5234EUR$5,950USD£4,542GBP

894 Results (Page 9 of 45)
- 1
- 7
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.